Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial Do Seon Song; Jin Mo Yang; Young Kul Jung; Hyung Joon Yim; Hee Yeon Kim; Chang Wook Kim; Soon Sun Kim; Jae Youn Cheong; Hae Lim Lee; Sung Won Lee; Jeong-Ju Yoo; Sang Gyune Kim; Young Seok Kim;

Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of Hepatology Aldo Torre; Laura Esthela Cisneros-Garza; Mauricio Castillo-Barradas; Nalu Navarro-Alvarez; Ricardo Sandoval-Salas; María Sarai González-Huezo; José Luís Pérez-Hernández; Osvely Méndez-Guerrero; Jesús Alejandro Ruiz-Manríquez; Rafael Trejo-Estrada; Norberto C. Chavez-Tapia; Luis Carlos Solís-Gasca; Carlos Moctezuma-Velázquez; Jonathan Aguirre-Valádez; Judith Flores-Calderón; Fatima Higuera-de-la-Tijera; Ignacio García-Juárez; Nancy Allin Canedo-Castillo; René Malé-Velázquez; Iaarah Montalvo-Gordon; Mario Vilatobá; Ernesto Márquez-Guillén; Jacqueline Córdova-Gallardo; Nayeli Cointa Flores-García; Godolfino Miranda-Zazueta; Belinda Isela Martínez-Saldívar; Víctor Manuel Páez-Zayas; Linda Elsa Muñoz-Espinosa; Francisco Alfonso Solís-Galindo;

A comprehensive meta-analysis of stem cell therapy for liver failure: Assessing treatment efficacy and modality Shenglong Lin; Haibing Gao; Huaxi Ma; Ziyuan Liao; Dongqing Zhang; Jinshui Pan; Yueyong Zhu;